Long-term use of ticagrelor in patients with prior myocardial infarction.

The New England Journal of Medicine
Marc P BonacaPEGASUS-TIMI 54 Steering Committee and Investigators

Abstract

The potential benefit of dual antiplatelet therapy beyond 1 year after a myocardial infarction has not been established. We investigated the efficacy and safety of ticagrelor, a P2Y12 receptor antagonist with established efficacy after an acute coronary syndrome, in this context. We randomly assigned, in a double-blind 1:1:1 fashion, 21,162 patients who had had a myocardial infarction 1 to 3 years earlier to ticagrelor at a dose of 90 mg twice daily, ticagrelor at a dose of 60 mg twice daily, or placebo. All the patients were to receive low-dose aspirin and were followed for a median of 33 months. The primary efficacy end point was the composite of cardiovascular death, myocardial infarction, or stroke. The primary safety end point was Thrombolysis in Myocardial Infarction (TIMI) major bleeding. The two ticagrelor doses each reduced, as compared with placebo, the rate of the primary efficacy end point, with Kaplan-Meier rates at 3 years of 7.85% in the group that received 90 mg of ticagrelor twice daily, 7.77% in the group that received 60 mg of ticagrelor twice daily, and 9.04% in the placebo group (hazard ratio for 90 mg of ticagrelor vs. placebo, 0.85; 95% confidence interval [CI], 0.75 to 0.96; P=0.008; hazard ratio for 60 ...Continue Reading

References

Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Feb 26, 2003·Circulation·Salim YusufUNKNOWN Clopidogrel in Unstable angina to prevent Recurrent Events Trial Investigators
Mar 11, 2005·The New England Journal of Medicine·Marc S SabatineUNKNOWN CLARITY-TIMI 28 Investigators
Mar 15, 2006·The New England Journal of Medicine·Deepak L BhattUNKNOWN CHARISMA Investigators
May 15, 2007·Journal of the American College of Cardiology·Deepak L BhattUNKNOWN CHARISMA Investigators
Nov 6, 2007·The New England Journal of Medicine·Stephen D WiviottUNKNOWN TRITON-TIMI 38 Investigators
Apr 12, 2008·The New England Journal of Medicine·John R Kapoor
Sep 1, 2009·The New England Journal of Medicine·Lars WallentinMona Thorsén
Sep 2, 2010·JAMA : the Journal of the American Medical Association·Deepak L BhattUNKNOWN REACH Registry Investigators
Nov 18, 2014·The New England Journal of Medicine·Laura MauriUNKNOWN DAPT Study Investigators
Dec 19, 2014·Circulation·Dariush MozaffarianUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee

❮ Previous
Next ❯

Citations

Oct 30, 2015·Expert Review of Cardiovascular Therapy·Victor L SerebruanyMoo Hyun Kim
Aug 22, 2015·Expert Opinion on Pharmacotherapy·Erik L GroveSteen Dalby Kristensen
Jun 19, 2015·Current Medical Research and Opinion·Scott A HardingPhilip E Aylward
Aug 18, 2016·European Heart Journal. Cardiovascular Pharmacotherapy·Giulia MagnaniMarc S Sabatine
Aug 18, 2016·European Heart Journal. Cardiovascular Pharmacotherapy·Pierre SabouretGilles Montalescot
Aug 8, 2015·European Heart Journal·Gilles Montalescot, Marc S Sabatine
Nov 21, 2015·European Heart Journal·Laura MauriUNKNOWN DAPT Study Investigators
Dec 20, 2015·European Heart Journal·William A E Parker, Robert F Storey
Sep 14, 2015·European Heart Journal·Gérard HelftUNKNOWN OPTImal DUAL Antiplatelet Therapy Trial Investigators
Jan 5, 2016·European Heart Journal·Gilles Montalescot, Filippo Crea
Jan 23, 2016·JACC. Cardiovascular Interventions·David R Holmes, Charanjit S Rihal
Oct 9, 2015·Pharmacoepidemiology and Drug Safety·Ricky D TurgeonMuhammad Mamdani
Jan 11, 2016·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Nicholas L CrudenSimon D Robinson
Jan 15, 2016·Mayo Clinic Proceedings·Laszlo Littmann, Michael H Monroe
Jan 15, 2016·Mayo Clinic Proceedings·Vinay Prasad, Vance W Berger
Mar 5, 2016·Drugs & Aging·Bianca Rocca, Steen Husted
Jan 23, 2016·Expert Opinion on Pharmacotherapy·Giuseppe GargiuloMarco Valgimigli
Dec 25, 2015·Journal of the American College of Cardiology·Stuart J PocockGregg W Stone
Aug 19, 2015·Progress in Cardiovascular Diseases·Francesco FranchiDominick J Angiolillo
Aug 19, 2015·Nature Reviews. Cardiology·Fabiana RolliniDominick J Angiolillo
Mar 12, 2016·Journal of the American College of Cardiology·Somjot S Brar
Mar 12, 2016·Journal of the American College of Cardiology·Robert F StoreyMarc S Sabatine
Feb 26, 2016·Current Treatment Options in Cardiovascular Medicine·Kristy Yuan, Anthony S Kim
Dec 17, 2015·Journal of the American College of Cardiology·Stuart J PocockTim J Collier
Jun 28, 2016·The Canadian Journal of Cardiology·David H FitchettAnatoly Langer
Oct 13, 2015·The American Journal of Cardiology·Guy WitbergRan Kornowski
Oct 4, 2015·Archives of Cardiovascular Diseases·Gérard Helft

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.